Resources
To help you recommend Eversense 365 with confidence and get patients started.
Product Videos
Patient Benefits
See how Eversense 365 is a long-term solution to the everyday frustrations of traditional, short-term CGMs.
How the Technology Works
Learn how the tiny sensor turns glucose molecules into light signals—all day, every day, for a YEAR.
Sensor Placement Procedure
See how simple sensor placement is for patients, and how the Eversense Inserter Network can take care of the process for you.
Industry Expert Webinar Series
Deepen your knowledge to enhance patient discussions with TCOYD Eversense 365 webinars:
Challenges with short-term CGMs.
Overview of Eversense 365 CGM system.
Patient case studies.
Coverage & Reimbursement
For patients with
Commercial Insurance
For your patients on insulin, Eversense 365 is covered by most commercial health plans‡. This includes Aetna, Cigna, Elevance (formerly Anthem), Humana, United Healthcare, most Blue Cross Blue Shield plans - and many others.
Eligible patients may pay as little as $199 for a full year with the Eversense PASS Programs†.
For patients with
Medicare
Eversense 365 CGM is covered by Medicare§.
Getting Patients Started
Refer Interested Patient
Have a patient who wants to learn more or check their coverage? Refer them to us.
Prescribe Eversense 365
Patient ready to get started? Send us CMN, Chart Notes and Insurance Info.
Send completed forms
to fax # 1-949-260-2618 or
eversenseenrollment@senseonics.com
Patient Resources
In-Office Materials
Looking for brochures, posters, or other patient materials? An Eversense Expert can help.
Patient Support
We provide training and end-to-end support. Check out our patient resources.
Eversense Data Management System (DMS) Pro
After your patient begins using Eversense 365, you will have access to dependable glucose data through Eversense DMS Pro that can help shape better and more effective treatment plans.
Clinical Evidence
Continuous Glucose Monitoring System: The ENHANCE Study
This report summarizes the 365-day clinical study. ENHANCE was a prospective, multicenter study evaluating the accuracy and safety of the Eversense 365 CGM system through 1 year in adults with diabetes.
Bibliography of
Eversense Studies
Peer-reviewed journal articles for relevant information on long-term CGMs.
Do You Have Questions?
